Elironrasib: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 2 Phase 2 2

Condition	Trials
Colorectal Cancer	2
Lung cancer	2
Non-Small Cell Lung Cancer (NSCLC)	2
Advanced Solid Tumors	1
CRC	1
Colorectal Cancer (CRC)	1
Metastatic Solid Tumors	1
NSCLC	1
Pancreatic Ductal Adenocarcinoma	1
Pancreatic cancer	1

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
NCT06128551 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 55 locations
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
NCT07397338 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations

2 recruiting trials across 10 conditions.

No. For the full record, search ClinicalTrials.gov.